What do primary care providers need to know about diabetes, atrial fibrillation, and heart failure? Dr. Matthew Freeby will address topics related to current type 2 diabetes care, with focus on education, medications and newer technologies. Dr. Karol Watson will discuss treatment and prevention of atrial fibrillation, and Dr. Jon Kobashigawa will discuss common questions about heart failure including risk factors, treatment options, lifestyle changes and prevention.
Practice-changing updates to the medical literature that are hot off the presses! Join Dr. Pam Kushner to discuss important changes in the 2021 ADA guidelines and examine recently published research on atrial fibrillation, lipids, reducing cardiovascular risk, coconut oil, patient communication, and much more!
What do primary care providers need to know about PCPs in Diabetes, atrial Fibrillation, Mild Cognitive Impairment? Join expert faculty as they review important questions they get asked about these topics!
Join Dr. Ty Gluckman as he dives deeper into the treatment of atrial fibrillation. This program will focus on rate and rhythm control and the pivotal role they play in alleviating symptoms of AF. Dr. Gluckman will discuss factors that would guide clinical decision making towards a strategy that focuses on rate vs rhythm control.
Guest: Robert Baldor, MD, FAAFP Music Credit: Richard Onorato
Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib.
Guest: Robert A. Baldor, MD, FAAFPMusic Credit: Richard Onorato
Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you’ll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you’ll walk away with practical knowledge to help these patients minimize their risk of adverse events.
Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato
Stroke is a major health problem, and the risk of stroke is five-times higher in individuals with atrial fibrillation (AF) than those without. AF can be asymptomatic or subclinical. In 18% of AF patients, the condition is only detected at the time of stroke. It is not known whether individuals whose AF is deterred via screening carry a similar risk to individuals with known AF. A recent randomized trial evaluated a screening program for AF in individuals at high risk of stroke; for individuals identified with AF, anticoagulation was given for stroke prevention.